Sean Lee CFA

Stock Analyst at H.C. Wainwright

(0.93)
# 3,988
Out of 5,070 analysts
270
Total ratings
31.9%
Success rate
-1.2%
Average return
Main Sectors:

Stocks Rated by Sean Lee CFA

Akari Therapeutics,
Oct 1, 2026
Reiterated: Buy
Price Target: $27
Current: $9.29
Upside: +190.64%
Dogwood Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $12
Current: $1.15
Upside: +943.48%
Kazia Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $18
Current: $7.88
Upside: +128.43%
Senseonics Holdings
Oct 1, 2026
Reiterated: Buy
Price Target: $14
Current: $8.21
Upside: +70.52%
Corvus Pharmaceuticals
Aug 10, 2026
Reiterated: Buy
Price Target: $27
Current: $10.23
Upside: +163.93%
Cytosorbents
Aug 7, 2026
Reiterated: Hold
Price Target: $15
Current: $5.32
Upside: +181.95%
Myomo
Aug 7, 2026
Reiterated: Buy
Price Target: $5
Current: $1.26
Upside: +296.83%
Alphatec Holdings
Aug 5, 2026
Reiterated: Buy
Price Target: $24
Current: $10.86
Upside: +120.99%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $11.43
Upside: +39.98%
Cerenome
Mar 16, 2026
Reiterated: Buy
Price Target: $25
Current: $1.68
Upside: +1,388.10%
Reiterated: Buy
Price Target: $4
Current: $0.1001
Upside: +3,896.00%
Reiterated: Buy
Price Target: $14
Current: $9.34
Upside: +49.89%
Reiterated: Buy
Price Target: €14.00
Current: €2.10
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $1.58
Upside: n/a
Reiterated: Buy
Price Target: $40
Current: $74.23
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a